Changes in Oncogene Expression Implicated in Evolution of Chronic Granulocytic Leukemia from its Chronic Phase to Acceleration

References

• Dickstein J.I., Vardiman J.W. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and myelodysplastic syndromes. Am. J. Clin. Pathol 1993; 99: 513–525
   PubMed Web of Science ®Google Scholar
• Kantarjian H.M., Talpaz M., Gutterman J.U. Chronic myelogenous leukemia: Past, present and future. Hematol. Pathol 1988; 2: 91–120
   PubMedGoogle Scholar
• Sokal J.E., Baccarani M., Russo D., Tura S. Staging and prognosis in chronic myelogenous leukemia. Semin. Hematol. 1988; 25: 49–61
   PubMed Web of Science ®Google Scholar
• Nowell P.C., Hungerford D.A. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497–1498
   Web of Science ®Google Scholar
• Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–295
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Stephenson J.R., Groffen J., Hansen P.F., de Klein A., Bartram C., Grosveld G. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 1983; 306: 239–242
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Lifshitz B., Gale R.P., Canaani E. Fused transcript of abl, bcr., genes in chronic myelogenous leukaemia. Nature 1985; 315: 550–554
   PubMed Web of Science ®Google Scholar
• Konopka J.B., Watanabe S.M., Witte O.N. An alteration of human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984; 37: 1035–1039
   PubMed Web of Science ®Google Scholar
• Cervantes F., Ballesta F., Mila M., Rozman C. Cytogenetic studies in blast crisis of Ph-positive chronic granulocytic leukemia: results and prognostic evaluation in 52 patients. Cancer Genet. Cytogenet. 1986; 21: 239–246
   PubMed Web of Science ®Google Scholar
• Liu E., Hjelle B., Bishop J.M. Transforming genes in chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 1988; 85: 1952–1956
   PubMed Web of Science ®Google Scholar
• LeMaistre A., Lee M.S., Talpaz M., Kantarjian H.M., Freireich E.J., Deisseroth A.B., Trujillo J.M., Stass S.A. RAS oncogene mutations are rare late stage events in chronic myelogenous leukemia. Blood 1989; 73: 889–891
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar-Eli M., Arlin Z., Advani S., Allen S.L., Goldman J., Snyder D., Foti A., Cline M. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest. 1991; 87: 2042–2047
   PubMed Web of Science ®Google Scholar
• McCarthy D.M., Goldman J.M., Rasool F.V., Graham S.V., Birnie G.D. Genomic alterations involving the c-myc proto-oncogene during the evolution of chronic granulocytic leukemia. Lancet 1984; 2: 1362–1365
   PubMed Web of Science ®Google Scholar
• Hjorth R., Jonsson A.K., Vretblad P. A rapid method for purification of human granulocytes using Percoll. A comparison with dextran sedimentation. J. Immun. Meth. 1981; 43: 95–101
   PubMed Web of Science ®Google Scholar
• Collins S.J., Groudine M.T. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc. Natl. Acad. Sci. USA. 1983; 80: 4813–4817
   PubMed Web of Science ®Google Scholar
• Collins S.J., Kubonishi I., Miyoshi I., Groudine M.T. Altered transcription of the c-abl oncogene in K562 and other chronic myelogenous leukemia cells. Science 1984; 225: 72–74
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Wong-Staal F., Gallo R.C. one., gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature 1982; 299: 61–63
   PubMed Web of Science ®Google Scholar
• Westin E.H., Wong-Staal F., Gelman E.P., Dalla-Favera R., Papas T.S., Lautenberger J.A., Eva A., Reddy E.P., Tronick S.R., Aaronson S.A., Gallo R.C. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc. Natl. Acad. Sci. USA. 1982; 79: 2490–2494
   PubMed Web of Science ®Google Scholar
• Westin E.H., Gallo R.C., Arya S.K., Eva A., Souza L.M., Baluda M.A., Aaronson S.A., Wong-Staal F. Differential expression of the amv gene in human hematopoietic cells. Proc. Natl. Acad. Sci. USA 1982; 79: 2194–2198
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Kantarjian H.M., Shtalrid M., Gutterman J.U., Talpaz M. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course. Blood 1990; 75: 445–452
   PubMed Web of Science ®Google Scholar
• Majello B., Kenyon L.C., Dalla-Favera R. Human c-myb proto-oncogene: nucleotide sequence of cDNA and organization of the genomic locus. Proc. Natl. Acad. Sci. USA. 1986; 83: 9636–9640
   PubMed Web of Science ®Google Scholar
• Kelly R.G., Cozzarelli N., Deutscher M.P., Lehman I.R., Romberg A. Enzymatic synthesis of deoxyribonucleic acid. J. Biol. Chem. 1970; 245: 39–45
   PubMed Web of Science ®Google Scholar
• White B.A., Bancroft F.C. Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J. Biol. Chem. 1982; 257: 8569–8572
   PubMed Web of Science ®Google Scholar
• Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Thomas P.S. Hybridization of denaturated RNA and smaller DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 1980; 77: 5201–5205
   PubMed Web of Science ®Google Scholar
• Kafatos F., Jones C., Efstratiadis A. Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucl. Acids Res 1979; 7: 1541–1552
   PubMed Web of Science ®Google Scholar
• Seabright M. A rapid banding technique for human chromosomes. Lancet 1971; 2: 971–972
   PubMed Web of Science ®Google Scholar
• Casperson T., Zeich L., Johansson C. Differential binding of alkylating fluorochromes in human chromosomes. Exp. CellRes 1970; 60: 315–319
   PubMed Web of Science ®Google Scholar
• International Society for Cytogenetic Nomenclature (ISCN). An international system for human cytogenetic nomenclature. Cytogenet. Cell Genet 1978; 21: 309–404
   PubMedGoogle Scholar
• Skorski T., Kanakaraj P., Ku D.H., Nieborowska-Skorska M., Canaani E., Zon G., Perussia B., Calabretta B. Negative regulation of p120GAP GTPase promoting activity by p120bcr/abl Implication for RAS-dependent Philadelphia chromosome positive cell growth. J. Exp. Med 1994; 179: 1855–1865
   PubMed Web of Science ®Google Scholar
• Slamon D.J., deKernion J.B., Verma I.M., Cline M.J. Expression of cellular oncogenes in human malignancies. Science 1984; 224: 256–262
   PubMed Web of Science ®Google Scholar
• McGahon A., Bissonette R., Schmitt M., Cotter K.M., Green D.R., Cotter T.G. BCR-ABL, maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994; 83: 1179–1187
   PubMed Web of Science ®Google Scholar
• Donner P., Greiser-Wilke I., Moelling K. Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus. Nature 1982; 296: 262–265
   PubMed Web of Science ®Google Scholar
• Evan G.L., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119–128
   PubMed Web of Science ®Google Scholar
• Romero P., Blick M., Talpaz M., Murphy E., Hester J., Gutterman J. C-sis, c-abl expression in chronic myelogenous leukemia and other hematologic malignancies. Blood 1986; 67: 839–841
   PubMed Web of Science ®Google Scholar
• Dainiak N., Davies G., Kalmanti M., Lawler J., Kulkarni V. Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro. J. Clin. Invest 1983; 71: 1206–1214
   PubMed Web of Science ®Google Scholar
• Collins S.J., Groudine M.T. Chronic myelogenous leukemia: Amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis. Blood 1987; 69: 893–898
   PubMed Web of Science ®Google Scholar
• Blick M., Romero P., Talpaz M., Kurzrock R., Shtalrid M., Andersson B., Trujillo J., Beran M., Gutterman J. Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genet. Cytogenet 1987; 27: 349–356
   PubMed Web of Science ®Google Scholar
• Rothberg P.G., Erisman M.D., Diehl R.E., Rovigatti U.G., Astrin S.M. Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies. Mol. Cell. Biol 1984; 4: 1096–1103
   PubMed Web of Science ®Google Scholar
• Ahuja H.G., Foti A., Bar-Eli M., Cline M. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 1990; 75: 1684–1690
   PubMed Web of Science ®Google Scholar
• Padau R.A., Carter G., Hughes D., Gow J., Farr C., Oscier D., McCormick F., Jacobs A. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization and transformation. Leukemia 1988; 2: 503–510
   PubMed Web of Science ®Google Scholar
• Stephenson J., Mufti G.J., Yoshida Y. Myelodys-plastic syndromes: from morphology to molecular biology. Part II. The molecular genetics of myelodysplasia. Int. J. Hematol. 1993; 57: 99–112
   PubMed Web of Science ®Google Scholar
• Isobe M., Emanuel B.S., Givol D., Oren M., Croce C.M. Localization of gene for human p53 tumor antigen to band 17p13. Nature 1986; 320: 84–86
   PubMed Web of Science ®Google Scholar
• Mori N., Wada M., Yokota J., Terada M., Okada M., Tesamura M., Masuda M., Hushino S., Motoji T., Oshimi K., Muzoguchi M. Mutations of the p53 suppressor gene in haematologic neoplasms. Br. J. Haematol. 1992; 81: 235–240
   PubMed Web of Science ®Google Scholar
• Cline M.J., Jat P.S., Foti A. Molecular mechanisms in the evolution of chronic myelocytic leukaemia. Leuk. Lymph 1992; 7: 283–286
   PubMed Web of Science ®Google Scholar
• Yunis J.J., Ramsay N. Retinoblastoma and sub-band deletion of chromosome 13. Am. J. Dis. Child 1978; 132: 161–165
   PubMedGoogle Scholar
• Kantarjian H.M., Keating M.J., Walters R.S., McCredie K.B., Smith T.L., Talpaz M., Beran M., Cork A., Trujillo J.M., Feireich E.J. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia. Cancer 1986; 58: 2023–2030
   PubMed Web of Science ®Google Scholar
• LeBeau M.M. Deletions of chromosome 5 in malignant myeloid disorders. Cancer Surv 1992; 15: 143–159
   PubMedGoogle Scholar
• Bernstein R. Cytogenetics of chronic myelogenous leukemia. Semin. Hematol. 1988; 25: 20–34
   PubMed Web of Science ®Google Scholar
• Nowell P. The clonal evolution of tumor cell populations. Science 1976; 194: 23–28
   PubMed Web of Science ®Google Scholar